Genentech Email Format

Biotechnology Research
10,001+ employees
South San Francisco, CA, USA

Genentech is a biotechnology research company that uses cutting-edge science to develop and deliver innovative medicines for difficult-to-treat conditions worldwide.

Find contacts at Genentech

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

last.first@gene.com

Company Overview

Industry
Biotechnology Research
Founded
1976
Headquarters
South San Francisco, CA, USA
Revenue
$5B-$10B
FUNDING Stage
Subsidiary
Key Executives
Ashley Magargee (Chief Executive Officer), Matteo Pietra (Chief Financial Officer), Wafaa Mamilli (Executive Vice President and Chief Digital Technology Officer)

Tech Stack

AWS

Cloud

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Genentech?

Genentech uses the last.first format on gene.com, so Jane Smith would be smith.jane@gene.com.

What therapeutic areas does Genentech focus on?

Genentech focuses on oncology, neuroscience, ophthalmology, immunology, and obesity, with medicines covering conditions from multiple sclerosis and blood cancers to eye diseases and respiratory conditions. You can verify specific contacts across these teams using Clay.

How many employees does Genentech have?

Genentech has approximately 18,129 employees and is headquartered in South San Francisco, California, where the campus also serves as the headquarters for Roche pharmaceutical operations in the United States.

Which Genentech medicines are used to treat multiple sclerosis?

Genentech markets Ocrevus and Ocrevus Zunovo for multiple sclerosis, including being the first medicine approved for primary progressive MS, as well as Enspryng for neuromyelitis optica spectrum disorder.

Who leads Genentech as its current Chief Executive Officer?

Ashley Magargee serves as the Chief Executive Officer of Genentech. Matteo Pietra holds the role of Chief Financial Officer and Wafaa Mamilli serves as Executive Vice President and Chief Digital Technology Officer.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles